VIVO Cannabis (OTCMKTS:VVCIF) is a Canada-based producer and distributor of medical and wellness cannabis products. The company’s origins trace back to its predecessor ABcann Medicinals, which began cultivating standardized, pharmaceutical-quality cannabis in 2017. After a rebranding in 2019, VIVO expanded its footprint through strategic acquisitions, evolving into a multi-faceted operator with in-house cultivation, processing and distribution capabilities. The company focuses on compliance with Health Canada’s Good Production Practices (GPP) to deliver consistent product quality for patients and adult-use consumers.
VIVO’s product portfolio includes dried flower, pre-rolls, cannabis oils and softgel capsules, along with vape cartridges and extracts tailored to medical and consumer markets. Its processing facility features automated extraction and formulation lines, enabling the development of proprietary formulations and value-added derivatives. The company also invests in research and development to explore novel delivery methods, including transdermal patches and topical creams designed to address pain management and wellness applications.
Operating primarily in Canada, VIVO serves provincial distribution systems for both medical and adult-use programs and has established export partnerships in Europe and Latin America. The company holds export permits for sales into regulated markets such as Germany, Denmark and Brazil, leveraging joint ventures and distribution agreements to reach patients and consumers abroad. Through its supply chain partnerships, VIVO aims to capitalize on global demand for high-quality, standardized cannabis products.
VIVO Cannabis is guided by a management team with deep expertise in horticulture, pharmaceutical development and corporate finance. The senior leadership group includes a Chief Executive Officer who previously held executive roles in major agricultural enterprises, supported by a Chief Financial Officer with extensive capital markets experience. The board of directors brings diverse backgrounds in life sciences, public company governance and international business, aligning corporate strategy with operational execution.
AI Generated. May Contain Errors.
